Tofacitinib 20 vs 30 mg in acute severe ulcerative colitis: a double-blind randomized controlled trial
Tofacitinib 20 vs 30 mg in acute severe ulcerative colitis: a double-blind randomized controlled trial
Anti-TNF withdrawal or long-term treatment in ulcerative colitis (BIOSTOP): a multicentre open label, randomized controlled trial
Ustekinumab for fistulising perianal Crohn’s disease: a randomised placebo-controlled trial from the GETAID
Efficacy and safety of duvakitug in patients with Crohn’s disease (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial
Efficacy and safety of duvakitug in patients with ulcerative colitis (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial
Tasty&Healthy exclusive whole food diet in asymptomatic children and young adults with biologically active Crohn’s disease: the TASTI-E randomized controlled trial